Differential transcriptomics in sarcoidosis lung and lymph node granulomas with comparisons to pathogen-specific...

Area of Science:

• Genomics
• Immunology
• Biomarker Discovery

Background:

• Sarcoidosis etiology and pathogenesis remain unclear due to limited preclinical models and biomarkers.
• Granulomas are central to sarcoidosis; direct genomic study of these tissues may reveal dysregulated pathways or signatures.
• Current multi-'omics' approaches have not fully elucidated sarcoidosis mechanisms.

Purpose of the Study:

• To develop genomic biomarkers for sarcoidosis.
• To perform gene expression profiling of sarcoidosis granulomas in lung and lymph node tissues.
• To compare sarcoidosis granulomas with those from infectious diseases like coccidioidomycosis and tuberculosis.

Main Methods:

• Transcriptomic profiling of immune-related genes from micro-dissected sarcoidosis granulomas.
• Comparison of gene expression in sarcoidosis granulomas (lung and lymph node) with infectious granulomas.
• Identification and analysis of differentially expressed genes (DEGs) and functional enrichment pathways.

Main Results:

• Sarcoidosis granulomas in lung and lymph nodes exhibit distinct DEG profiles and pathway enrichments.
• Lymph node granulomas show an immunological response, while lung granulomas display a regenerative response.
• New genomic markers (ADAMTS1, NPR1, CXCL2) were identified, corroborating some known biomarkers and excluding others.

Conclusions:

• Tissue-specific evaluation is crucial for identifying sarcoidosis genomic markers.
• Gene expression analysis provides insights into sarcoidosis pathogenesis and distinguishes it from similar infections.
• This study offers specific genomic biomarkers for sarcoidosis diagnosis and prognosis.